A Comparetaive Study on Glucantime and Oral Terbinafine along with Systemic Glucantime on Cutaneous Leishmaniasis

Document Type : Original Article (s)

Authors

1 Student of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.

2 Professor, Department of Dermatology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.

3 Associate Professor, Department of Dermatology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.

Abstract

Background: Cutaneous leishmaniasis is the endemic type of leishmaniasis in Iran especially Isfahan province. Pentavalent antimonials are the first line treatment in all kind of leismaniasis; but their high cost side effect and also injection from, shows the necessity of finding new ways of treatment with more affectivity and lower side effect.Methods: A clinical trial that was performed in autumn and winter of 1387 on patients coming to center of skin investigation and skin clinics. 90 patients entered randomizely into case and control group, 85 of control group and 75 of case group referred for follow up. Statistical analysis was done with SPSS. In this investigation the mean reduce in size of lesions in case group was - 9.55 and in control group was -5.33 and p 0.001 so it was meaning full.Finding: The mean reduce in duration of lesions in case group was -5.2 and pvalue under 0.001 so it was meaning full. Complete cure in case group was %80 partial improvement %8 and no change %9 and control group cure was %52.9 partial improvement was %11.8 and no change was %35.3 compare of improvement in two groups shows That improvement in case group has been meaning fully more than Control group that can be because of the effect of terbinafin on treatment of cutaneous leishmaniasis.

Keywords

References

  1. Karin L , Weller Pf. Epidemiology and clinical manifestation of leishmaniasis. 2009. Uptodate. Available at: URL: http://www.Uptodate.com.mar 20, 2009.
  2. Herwalt Bl,Stokes Sl, Juranek Dd. American cutaneous leishmaniasis in U.S travelers. Ann Intern med 1993; 118: 779.
  3. Epidemiology of the leishmaniasis. Dermatol clin 1995; 13:505.
  4. Scrope A, Trau H , Balcon M, etal. Experience with new world cutaneous leishmaniasis in travelers. J AM Acad Dermatol 2003; 49:6
  5. Nlforoush Zadeh A, Sadeghian G. Cutaneous
  6. Leishmaniasis. Isfahan : Isfahan University of Medical Sciences; 2002. 52-9.
  7. Vanniersantons MA.Alternations induced by antifungal compound ketokonazole and terbinafin in leishmania.J eukaryote Microbi-al,1995,42(4):337-346.
  8. Benhamdan KH.Terbinafin in treatment of cutaneous leishmaniasis:a pilot study.International J of Dermatology,1997,36:50-60.
  9. Zakai HA,Zimmo SK.Effects of itraconazole and terbinafine on leishmania major lesions in BALB/c mice.J of tropical medicin and parasitology,2000,94(8):787-791.
Journal of Isfahan Medical School
Volume 28, Issue 118 - Serial Number 118
November and December 2011
Pages 1246-1252

Files

History

  • Receive Date: 19 March 2011
  • Revise Date: 08 May 2024
  • Accept Date: 06 April 2022

Share

How to cite

Statistics